Impact of statins on the coagulation status of type 2 diabetes patients evaluated by a novel thrombin-generation assay

P. Ferroni, D. Della-Morte, A. Pileggi, M. G. Valente, F. Martini, F. La Farina, R. Palmirotta, L. F. Meneghini, T. Rundek, C. Ricordi, F. Guadagni

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose Dyslipidemia is common in type 2 diabetes (T2D) and contributes to cardiovascular disease (CVD) by exacerbating atherosclerosis and hypercoagulability. Statins can stabilize atherosclerotic plaque and reduce prothrombotic status. In the present study we aimed to evaluate the coagulation activity and the effect of statins on procoagulant state of T2D patients using a novel activated protein C (APC)-dependent thrombin-generation assay. Methods Procoagulant status (by HemosIL ThromboPath (ThP) assay) and in vivo platelet activation (by plasma soluble (s)CD40L levels) were analyzed in a retrospective, cross-sectional study of 198 patients with long-standing T2D and 198 controls. Results Procoagulant status of T2D patients was enhanced when compared to control subjects (p

Original languageEnglish
Pages (from-to)301-309
Number of pages9
JournalCardiovascular Drugs and Therapy
Volume26
Issue number4
DOIs
Publication statusPublished - Aug 2012

Keywords

  • Dyslipidemia
  • Haemostasis
  • Lipid-Lowering Drugs
  • Type 2 Diabetes

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Cardiology and Cardiovascular Medicine
  • Pharmacology

Fingerprint Dive into the research topics of 'Impact of statins on the coagulation status of type 2 diabetes patients evaluated by a novel thrombin-generation assay'. Together they form a unique fingerprint.

Cite this